Cuban 'acoustic attack' report on US diplomats flawed, say neurologists
Tests stating staff suffered brain damage were ‘misinterpreted’ and ruled out other explanations such as mass psychogenic illnessClaims that US diplomats suffered mysteriousbrain injuries after being targeted with a secret weapon in Cuba have been challenged by neurologists and other brain specialists.Amedical report commissioned by the US government, published in March, found that staff at the US embassy in Havana suffered concussion-like brain damage after hearing strange noises in homes and hotels, but doctors from the US, the UK and Germany have contested the conclusions.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 14, 2018 Category: Science Authors: Ian Sample Science editor Tags: Cuba Neuroscience Americas World news US news FBI Source Type: news

Don ’t be in any doubt – ADHD is an illness and it must be treated | Ann Robinson
Britain is right to take a more cautious approach than the US, but we should be prepared to fund a range of treatmentsImagine a neurological condition that affects one in 20 under-18s. It starts early, causes significant distress and pain to the child, damages families and limits the chances of leading a fulfilled life as an adult. One in 20 children are affected but only half of these will get a diagnosis and a fifth will receive treatment. If those stats related to a familiar and well-understood illness, such as asthma, there would be little debate about the need to improve intervention rates. But this is attention ...
Source: Guardian Unlimited Science - August 13, 2018 Category: Science Authors: Ann Robinson Tags: Attention deficit hyperactivity disorder Children NHS Health Medical research Society Science Source Type: news

SNMMI honors outstanding contributors at 2018 annual meeting
(Society of Nuclear Medicine and Molecular Imaging) The Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization, recognized contributions to the field of nuclear medicine and molecular imaging during its 2018 Annual Meeting in Philadelphia. Several awards ceremonies were held to recognize the valuable role SNMMI members play in advancing the diagnosis and treatment of heart disease, cancer and neurological conditions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 13, 2018 Category: International Medicine & Public Health Source Type: news

MD Anderson and Accelerator Life Science Partners launch Magnolia Neurosciences
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, today announced the launch of Magnolia Neurosciences Corporation, a company developing a new class of neuroprotective medicines, with $31 million in Series A funding. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 13, 2018 Category: International Medicine & Public Health Source Type: news

Weekly Postings
See something of interest? Please share our postings with colleagues in your institutions! Spotlight Member Highlights: Let us shine a spotlight on the amazing work you do! NNLM MAR is always interested in learning about health outreach projects and activities that are happening in Pennsylvania, New York, New Jersey and Delaware. Share your story with us to receive a Member Highlight on the MARquee! Local lecture from NLM Director: the recording is now available from Dr. Patricia Flatley Brennan’s talk, “Transforming Data into Knowledge and Knowledge into Health: NLM Strategic Plan 2017-2027,” at the Univ...
Source: NN/LM Middle Atlantic Region Blog - August 10, 2018 Category: Databases & Libraries Authors: Hannah Sinemus Tags: Weekly Postings Source Type: news

Studies Unable to Reproduce Results of Two Diabetes Papers
The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice. (Source: The Scientist)
Source: The Scientist - August 10, 2018 Category: Science Tags: News & Opinion Source Type: news

ElectroCore inks nVNS neuroinflammatory response research deal with MGH
ElectroCore said yesterday it inked a collaborative research deal with Massachusetts General Hospital exploring the use of ElectroCore’s non-invasive vagus nerve stimulation tech in targeted treatments for neuroinflammation. The Basking Ridge, N.J.-based company said that investigators will examine the effects the nVNS system has on neuroinflammatory mechanisms associated with conditions in the central nervous system including pain, trauma and neurodegeneration. ElectroCore said it will supply up to $1 million through a research grant over four years to support preclinical trials of the device, including work al...
Source: Mass Device - August 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Neurological Neuromodulation/Neurostimulation electroCore Source Type: news

Vaccine Being Tested To Prevent Dementia In People With Down Syndrome
BOSTON (CBS) – Local researchers are testing an experimental vaccine that may not only prevent Alzheimer’s disease in people with Down syndrome, but in those without Down syndrome as well. People with Down syndrome are at high risk of developing Alzheimer’s-like dementia at a very young age. Michael Clayburgh, 29, has Down syndrome, but that doesn’t hold him back. “Michael has three jobs,” says Nancy Novelline Clayburgh, Michael’s mom.  “He works at Target, McDonald’s and Dunkin Donuts.” Dr. Brian Skotko and Michael Clayburgh (WBZ-TV) He’s also qui...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 9, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated Local Alzheimer's Disease Dementia Down Syndrome Dr. Mallika Marshall Source Type: news

Methyl marks on RNA discovered to be key to brain cell connections
FINDINGSMethyl chemical groups dot lengths of DNA, helping to control when certain genes are accessible by a cell. In new research, UCLA scientists have shown that at the connections between brain cells — which often are located far from the central control centers of the cells — methyl groups also dot chains of RNA. This methyl markup of RNA molecules is likely key to brain cells’ ability to quickly send signals to other cells and react to changing stimuli in a fraction of a second.BACKGROUNDTo dictate the biology of any cell, DNA in the cell ’s nucleus must be translated into corresponding strands...
Source: UCLA Newsroom: Health Sciences - August 9, 2018 Category: Universities & Medical Training Source Type: news

Former Students Allege Mistreatment of Lab Animals at Calgary
The university is carrying out a review of animal handling in the now-closed lab of neuropsychologist Vedran Lovic. (Source: The Scientist)
Source: The Scientist - August 9, 2018 Category: Science Tags: News & Opinion Source Type: news

Function of gene mutations linked to neurological diseases identified
New research by Yale investigators into the function of VPS13 proteins may help to develop new therapies for Parkinson ’s disease. (Source: Yale Science and Health News)
Source: Yale Science and Health News - August 9, 2018 Category: Universities & Medical Training Source Type: news

Lowering Your Blood Pressure Could Reduce Alzheimer ’s Risk, New Research Shows
Margaret Daffodil Graham tries to live a healthy life, particularly since she has a health issue that requires constant attention. Like more than 100 million other Americans, the 74-year-old from Winston-Salem, N.C., has high blood pressure, and she has been taking medication to control it since she was in her 30s. So when she read that her nearby hospital, Wake Forest Baptist Medical Center, was looking for people with hypertension to volunteer for a study, she quickly signed up, knowing the doctors would monitor her blood pressure more intensively and hopefully lower her risk of developing heart disease and stroke. What...
Source: TIME: Science - August 9, 2018 Category: Science Authors: Alice Park Tags: Uncategorized Aging Alzheimer's Research Source Type: news

Are The Health Benefits Of Turmeric Too Good To Be True?
(CNN) — Alzheimer’s disease. Diabetes. Arthritis. Unwanted hair growth. Baldness. Infertility. Erectile dysfunction. Hangovers. Glaucoma. Cancer. If you have an ailment, there’s a good chance that someone, somewhere, is studying whether turmeric can treat it. There are more than 15,000 manuscripts published about curcumin, the active ingredient in turmeric, and about 50 manuscripts added to this collection each week, according to the National Institutes of Health. “It’s really taken on sort of panacea-like properties in terms of the things it’s being studied for and the things it has bee...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 7, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local TV turmeric Source Type: news

UCLA bioengineers show magnetic gel ’s use to ease pain
UCLA bioengineers have demonstrated that a gel-like material containing tiny magnetic particles could be used to manage chronic pain from disease or injury. Broadly, the study demonstrates the promising use of biomechanical forces  that push and pull on cells to treat disease.“Much of mainstream modern medicine centers on using pharmaceuticals to make chemical or molecular changes inside the body to treat disease,” said Dino Di Carlo, UCLA professor of bioengineering and the principal investigator of the study. “However, recent breakthroughs in the control of force s at small scales have opened up a ...
Source: UCLA Newsroom: Health Sciences - August 7, 2018 Category: Universities & Medical Training Source Type: news

New Neuronal Markers
Check Them Out!We continue to addnew antibodies. Many are additions to our frequently used and widely publishedNeuron-Glial Markers.Image: Immunofluorescent analysis of cortical neuron-glial cell culture from E20 rat stained with mouse mAb to GAP43, MO22170, dilution 1:1,000, in red, and costained with chicken pAb to MAP2, dilution 1:10,000, in green. The blue is DAPI staining of nuclear DNA. GAP43 antibody labels protein expressed in the axonal membrane of the neuronal cells, while the MAP2 antibody stains dendrites and perikarya of neurons. Name Species Applications Aurora A/B Kinase Human, Mouse, Rat ICC, WB, IHC, IF Au...
Source: Neuromics - August 7, 2018 Category: Neuroscience Tags: DJ1 Antibody GAP43 Antibody Ki67 antibody. Vimentin Antibody nestin antibody OPA1 Antibody Tuj 1 antibody Source Type: news

Q and A: Scientist and Advocate BethAnn McLaughlin
The neuroscientist talks about her experiences with trying to change how the scientific community copes with sexual assault and harassment. (Source: The Scientist)
Source: The Scientist - August 7, 2018 Category: Science Tags: News & Opinion Source Type: news

How axons change chemical cues to mechanical force
(Nara Institute of Science and Technology) Neural networks in the brain form by an axon extending from one neuron to interact with another. Chemical cues in the neuron microenvironment are responsible for activating the extending axon, but which molecular factors are responsible for interpreting this chemical information into a mechanical force for the axon to reach its destination has been unclear. Researchers at the Nara Institute of Science and Technology show shootin1 to be this mysterious factor. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 7, 2018 Category: International Medicine & Public Health Source Type: news

Boston Scientific to Layoff 85 Massachusetts Workers by Year End
Boston Scientific, which has been making acquisitions left and right this year, plans to lay off 85 workers at a Burlington, MA-based facility that came with the company's acquisition of Cosman Medical in 2016. Cosman developed radiofrequency ablation technology for the treatment of chronic pain and was integrated into Boston Scientific's neuromodulation business. The company submitted a Worker Adjustment and Retaining Act (WARN) report in Massachusetts disclosing the layoffs. The headcount reduction is expected to begin Sept. 28 and continue through December. When Boston Scientific acquired Cosman in July 2016, the financ...
Source: MDDI - August 7, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

President's USFS, DOE, and CEQ Nominees Advancing through Senate
Several nominations for key science and environmental posts in the Trump Administration are advancing through the confirmation process in the Senate. The Senate Agriculture Committee has approved President Trump’s nominee, James Hubbard, for Undersecretary of Agriculture for Natural Resources and Environment. Hubbard, a former Colorado state forester, will oversee the United States Forest Service. Hubbard has received support from forest industry groups and foresters for his experience with forest policy. He retired from his position as Deputy Forest Service Chief for State and Private Forestry in 2017. He has serve...
Source: Public Policy Reports - August 6, 2018 Category: Biology Authors: AIBS Source Type: news

Boston Scientific to lay off 85 at Burlington, Mass.-based facility
Boston Scientific (NYSE:BSX) laying off 85 workers at its Burlington, Mass.-based facilities, according to a recently filed Massachusetts Worker Adjustment and Retraining Act report. The company acquired the Burlington, Mass.-based location during its acquisition of Cosman Medical, which closed in July 2016. Cosman Medical produced radiofrequency ablation tech and was folded into the company’s neuromodulation business. The layoffs are set to go into effect beginning September 28 and proceeding through December, according to the notice. Last week, Boston Scientific said that it closed the $270 million buyout of&n...
Source: Mass Device - August 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Boston Scientific Source Type: news

Navigating the Chaos
" If you ’re not confused, you’re not paying attention.”This quote from best-selling author and business guru Tom Peters ’Thriving On Chaos could have been written for pharma right now.Megatrends disrupt the landscape, while political and economic uncertainties make predicting the future a fool ’s game. Chaos is everywhere, not least in patient access.How companies respond may well have a lot to do with that eternal question – is the glass half-full or half-empty?“I like the uncertainty that chaos brings in filling up that glass,” says John A. Bardi, VP, Public Affairs a...
Source: EyeForPharma - August 6, 2018 Category: Pharmaceuticals Authors: Adam Chapman Source Type: news

Boston Scientific to cut 85 jobs at Burlington site
Boston Scientific Corp., one of the state's largest medical device companies, has disclosed a new round of layoffs. According to documents filed with the state on Friday under the Worker Adjustment and Retraining Act, Marlborough-based Boston Scientific (Nasdaq: BSX) plans to cut 85 employees at a facility in Burlington between September and December. Boston Scientific has been operating at the site since acqui ring Cosman Medical Inc. in July 2016. The facility makes so-called "neuromodulation"… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 6, 2018 Category: Health Management Authors: Allison DeAngelis Source Type: news

Boston Scientific to cut 85 jobs at Burlington site
Boston Scientific Corp., one of the state's largest medical device companies, has disclosed a new round of layoffs. According to documents filed with the state on Friday under the Worker Adjustment and Retraining Act, Marlborough-based Boston Scientific (Nasdaq: BSX) plans to cut 85 employees at a facility in Burlington between September and December. Boston Scientific has been operating at the site since acqui ring Cosman Medical Inc. in July 2016. The facility makes so-called "neuromodulation"… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 6, 2018 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

People process bad news better under stress
(Society for Neuroscience) Threat dissolves the human tendency to readily accept good news over bad, according to experiments conducted both in the lab and with on-duty firefighters. The findings, published in JNeurosci, provide a potential mechanism by which levels of optimism are adapted to the relative safety or danger of the environment. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 6, 2018 Category: International Medicine & Public Health Source Type: news

How Sleep Affects Your Relationships, According to Science
In a properly functioning body, sleep helps the brain process your emotions and memories from the day. You wake up well-rested with enough mental space to both create and log new memories and work through the experiences of your day. Sleep deprivation, on the other hand, is like falling into an icy river: “The body shuts down circulation to the appendages and tries to keep the core warm. It goes into survival mode,” says W. Christopher Winter, a neurologist based in Charlottesville, VA and the author of The Sleep Solution. When you’re not sleeping well, “your brain’s ability to do things gets ...
Source: TIME: Health - August 3, 2018 Category: Consumer Health News Authors: Cassie Shortsleeve  Tags: Uncategorized Living relationships sleep Source Type: news

The 10 most innovative medical devices of 2018
The nominees for the best medical technology of 2018 were recently announced for the 12th Annual Prix Galien USA Awards. The host of the awards, The Galien Foundation, awards the Prix Galien Award annually to examples of outstanding biomedical and technology product achievements that are designed to improve human condition. Before the candidates can qualify for the award, their products need to be FDA approved for market within the last five years. They also have to show major potential to impact healthcare. The winners will be announced in October this year. This year, the foundation selected 20 nominees for “Best P...
Source: Mass Device - August 3, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Diabetes Diagnostics Drug-Device Combinations Imaging mHealth (Mobile Health) Neurological Patient Monitoring Abbott Boston Scientific BrainScope Foundation Medicine integralifesciences Koning Corp. MedTech Medtronic Otsuka H Source Type: news

Nevro ’ s Q2 losses exceed expectations
Although it pared its second-quarter losses on strong revenue growth, Nevro Corp. (NYSE:NVRO) missed the consensus earnings forecast yesterday due to increased labor costs and a legal battle with spinal cord stimulation rival Boston Scientific (NYSE:BSX). Redwood City, Calif.-based Nevro posted losses of -$10.7 million, or -35¢ per share, on sales of $96.1 million for the three months ended June 30, cutting losses by -7.6% on sales growth of 23.2% compared with Q2 2017. Analysts were looking for losses of -31¢ on sales of $95.3 million. Nevro said its operating expenses rose on “increased headcoun...
Source: Mass Device - August 3, 2018 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Neuromodulation/Neurostimulation Wall Street Beat nevro Source Type: news

Boston Scientific closes $270m Claret Medical buy
Boston Scientific (NYSE:BSX) said yesterday that it closed the $270 million buyout of Claret Medical and its Sentinel device, including a $50 million earnout pegged to a reimbursement win that just came in. Claret’s Sentinel device is designed to trap and remove debris dislodged during transcatheter aortic valve replacements to prevent stroke and other neurological damage. The deal, announced July 20, originally called for an up-front cash payment of $220 million plus the $50 million reimbursement milestone. That milestone was reached when the Centers for Medicare & Medicaid Services granted&n...
Source: Mass Device - August 3, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Replacement Heart Valves Wall Street Beat Boston Scientific Claret Medical Inc. Source Type: news

Brain & Behavior Research Foundation announces awards for exceptional research
(Brain& Behavior Research Foundation) The Brain& Behavior Research Foundation announced the winners of its 2018 Klerman and Freedman Prizes recognizing exceptional clinical and basic research. The grant program enables scientists who are early in their careers pursue innovative ideas in neurobiological and psychosocial research, gather pilot data and generate 'proof of concept' for the early detection, treatment, prevention and cures for mental illness. The awards were presented by Dr. Herbert Pardes, President of the Foundation's Scientific Council. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 3, 2018 Category: International Medicine & Public Health Source Type: news

BrainScope Receives Prix Galien Award Nomination for Its Concussion and Traumatic Brain Injury Assessment Product
BETHESDA, Md.--BrainScope today announced its second consecutive nomination for the 2018 Annual Prix Galien USA Awards for “Best Medical Technology” product. Its flagship BrainScope One product is a multi-modal, comprehensive, handheld capability to help clinicians objectively and rapidly assess and triage head injured patients directly at the point of care. BrainScope’s innovative technology addresses a vast market need for the global epidemic of mild head injury, which impacts more people each year than stroke and heart failure combined. BrainScope One is the first FDA-cleared medica...
Source: JEMS Patient Care - August 2, 2018 Category: Emergency Medicine Authors: Brainscope Tags: Trauma Product Announcements News Industry News Source Type: news

BrainScope Receives Prix Galien Award Nomination for Its Concussion and Traumatic Brain Injury Assessment Product
BETHESDA, Md.--BrainScope today announced its second consecutive nomination for the 2018 Annual Prix Galien USA Awards for “Best Medical Technology” product. Its flagship BrainScope One product is a multi-modal, comprehensive, handheld capability to help clinicians objectively and rapidly assess and triage head injured patients directly at the point of care. BrainScope’s innovative technology addresses a vast market need for the global epidemic of mild head injury, which impacts more people each year than stroke and heart failure combined. BrainScope One is the first FDA-cleared medica...
Source: JEMS: Journal of Emergency Medical Services News - August 2, 2018 Category: Emergency Medicine Authors: Brainscope Tags: Trauma Product Announcements News Industry News Source Type: news

UCLA researcher uses virtual reality to understand how animals perceive space
UCLA Health Nobody thinks much about how to navigate from the sofa to refrigerator. Memorizing sensory cues along the way, like the sight of the dining room table or a kitchen countertop, requires no conscious effort. You may not realize it, but your brain is processing data faster than any super computer, rapidly constructing a mental map based on sensory inputs as you move through your house.  When healthy, we don ’t appreciate this gift. However, spatial memory is one of the first functions to deteriorate in several neurological conditions including epilepsy and Alzheimer’s disease. That is why UCL...
Source: UCLA Newsroom: Health Sciences - August 2, 2018 Category: Universities & Medical Training Source Type: news

Image of the Day: Scatterbrain
Distributed neuronal networks help the brain sort smells. (Source: The Scientist)
Source: The Scientist - August 2, 2018 Category: Science Tags: Image of the Day Source Type: news

An opportunity for deeper and more targeted intervention of brain disorders
(American Association for the Advancement of Science) Nir Grossman is the 2018 grand prize winner of the Science& PINS Prize for Neuromodulation, for his research on a new strategy to stimulate deep and specific regions of the brain without surgery. His approach, described in his essay 'Modulation without surgical intervention,' may someday benefit patients with brain disorders for whom first- and second-line interventions, such as talk therapy or drugs, are ineffective. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 2, 2018 Category: International Medicine & Public Health Source Type: news

Metabolomics applications for precision nutrition, formula, & neurodegenerative disorders
(Mary Ann Liebert, Inc./Genetic Engineering News) Metabolomics is the latest omics systems science technology with emerging applications towards psychiatry, personalized medicine, and most recently, precision nutrition research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 2, 2018 Category: International Medicine & Public Health Source Type: news

Medical News Today: Do brain-training games really work?
New scientific evidence challenges the alleged cognitive benefits of brain-training games. Exercise and sleep may be better ways to boost cognition. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 1, 2018 Category: Consumer Health News Tags: Neurology / Neuroscience Source Type: news

As Brain Organoids Mature, Ethical Questions Arise
Inserting human "mini-brains" into rodents has the potential to broaden scientists’ understanding of neurological disease, but raises quandaries about consciousness. (Source: The Scientist)
Source: The Scientist - August 1, 2018 Category: Science Tags: Features Source Type: news

First drug to prevent chronic migraines approved by EU
Manufacturer says patients will be able to get treatment privately from September under EU licenceThe first ever drug specifically designed to prevent a migraine has been given the green light by European health officials.Erenumab is now expected to be considered by English and Scottish health agencies to assess whether it is appropriate for NHS use.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 31, 2018 Category: Science Authors: Press Association Tags: Science Medical research Health Neuroscience Society Source Type: news

NIDCR Science News
Having trouble viewing this email? View it as a Web page. Dentists Play Vital Role in Addressing Opioid Crisis Somerman and Volkow JADA commentary highlights efforts to reduce risk for opioid misuse. NIDCR • July 25, 2018   Dental Plaque Is No Match for Catalytic NanoparticlesUniversity of Pennsylvania • July 31, 2018 Researchers Are First to Sequence Rare Bacteria that Causes Rampant Tooth DecayUniversity of Illinois at Urbana-Champaign • July 24, 2018 UCLA Researchers Discover Gene t...
Source: NIDCR Science News - July 31, 2018 Category: Dentistry Source Type: news

Easy Immunostaining Staining
10X the Signal at a Fraction of the CostTime is money. This is especially true of routine immunostaining assays.We are pleased to introduce you toEZ-HRPTM Polymer Detection. Features include:10-15 times more sensitive than conventional avidin-biotin detection Allows for entire staining procedure to be completed in just under 2 hours Requires less primary antibody (3-4 times less) Does not produce non-specific background staining Can be used on unfixed or chemical fixed (formalin, formaldehyde, alcohol, etc), paraffin-embedded and frozen tissue sections.Comparison of IHC images using EZ-HRP ™ Polymer vs. a c...
Source: Neuromics - July 31, 2018 Category: Neuroscience Tags: HRP-Staining. Immunofluorescence Immunonostaining Source Type: news

First ever pill to prevent chronic migraines approved by EU
Manufacturer says patients will be able to get the drug privately from September under EU licenceThe first ever drug specifically designed to prevent a migraine has been given the green light by European health officials.Erenumab is now expected to be considered by English and Scottish health agencies to assess whether it is appropriate for NHS use.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 31, 2018 Category: Science Authors: Press Association Tags: Science Medical research Health Neuroscience Society Source Type: news

'Serendipitous' discovery at OHSU primate center may speed gene therapy
Researchers discovered a naturally occurring form of a deadly childhood neurodegenerative condition in a small population of macaque monkeys at the Oregon National Primate Research Center. The discovery provides a unique — and unexpected — opportunity for Oregon Health& Science University scientists to develop gene-therapy treatments to stop the progression of Batten disease. “It was accidental, but I’ve been calling it serendipitous, in the sense that we didn’t breed these animals to… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 30, 2018 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

'Serendipitous' discovery at OHSU primate center may speed gene therapy
Researchers discovered a naturally occurring form of a deadly childhood neurodegenerative condition in a small population of macaque monkeys at the Oregon National Primate Research Center. The discovery provides a unique — and unexpected — opportunity for Oregon Health& Science University scientists to develop gene-therapy treatments to stop the progression of Batten disease. “It was accidental, but I’ve been calling it serendipitous, in the sense that we didn’t breed these animals to… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 30, 2018 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

Nevro, Boston Scientific bury the hatchet
Nevro (NYSE:NVRO) said today that it agreed to bury the hatchet with Boston Scientific (NYSE:BSX) in their patent infringement spat over high-frequency spinal cord stimulation technology, sending its share prices up in mid-day trading. Last week a federal judge in California issued a mixed ruling in the case, finding that six claims in three of the Nevro patents are eligible but also that Boston’s SCS devices don’t infringe those claims (Boston doesn’t have a competing high-frequency SCS device on the U.S. market). Judge Vince Chhabria of the U.S. District Court for Northern Calif...
Source: Mass Device - July 30, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Legal News Neuromodulation/Neurostimulation Patent Infringement Boston Scientific nevro Source Type: news

Image of the Day: Squeeze In
A novel system lets researchers examine the neuromuscular features of a hydra. (Source: The Scientist)
Source: The Scientist - July 30, 2018 Category: Science Tags: Image of the Day Source Type: news

What keeps the brain awake
(Society for Neuroscience) A study of fruit flies has identified a pathway in the brain that keeps the animals from falling asleep during the day. The research, published in eNeuro, may have implications for understanding the sleep/wake cycle in mammals, which shares similar features. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 30, 2018 Category: International Medicine & Public Health Source Type: news

The heritability of anxiety
(Society for Neuroscience) Individual differences in the connectivity between regions of the brain involved in fear and anxiety are heritable, according to a large study of hundreds of related monkeys published in JNeurosci. The research provides new insights into the risk and development of anxiety disorders. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 30, 2018 Category: International Medicine & Public Health Source Type: news

How time affects learning
(Society for Neuroscience) Associations between neutral stimuli and monetary rewards are strengthened over the course of weeks, according to a human study published in JNeurosci that investigated learning over an extended period of time. The research may have implications for the study of addiction, in which learned associations between drug and reward are acquired gradually. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 30, 2018 Category: International Medicine & Public Health Source Type: news

Concussion: A History of Science and Medicine, 1870-2005 Concussion: A History of Science and Medicine, 1870-2005
This essay highlights key research and discoveries from the long history of concussion science. How have perceptions, attitudes and understanding evolved since the mid-19th century?Headache (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Scientists discover neurodegenerative disease in monkeys
(Oregon Health& Science University) OHSU scientists have discovered a naturally occurring disease in monkeys that mimics a deadly childhood neurodegenerative disorder in people -- a finding that holds promise for developing new gene therapies to treat Batten disease. Scientists confirmed through genetic analysis that a small population of Japanese macaque monkeys carry a mutation in the CLN7 gene that causes one form of the disease. It's the only known model for the disease among non-human primates in the world. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 27, 2018 Category: International Medicine & Public Health Source Type: news